Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration.

Similar presentations


Presentation on theme: "Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration."— Presentation transcript:

1 Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration Office of Surveillance and Biometrics Office of Device Evaluation

2 Medical Device Reporting Beverly Gallauresi RN, MPH Division of Postmarket Surveillance Office of Surveillance and Biometrics

3 3 Oscar H Tovar CDRH / FDA/ DHHS MDR – A Brief Description ● Nationwide passive surveillance mandatory and voluntary reports ● Reporters manufacturers, importers user facilities voluntary ● Types of reports deaths serious injuries malfunctions

4 4 Oscar H Tovar CDRH / FDA/ DHHS What is an Adverse Event ? An event whereby a medical device has, or may have, caused or contributed to a death or serious injury. Includes events associated with: - device failure- improper / inadequate design - device malfunction- manufacturing (problems) - use error- labeling (problems)

5 5 Oscar H Tovar CDRH / FDA/ DHHS MAUDE Manufacturer and User Facility Device Experience

6 6 Oscar H Tovar CDRH / FDA/ DHHS Methodology for Data Retrieval ● Product code ● August 1996 - December 2003

7 7 Oscar H Tovar CDRH / FDA/ DHHS Manufacturer Reports August 1996 - December 2003 ● DEATH 590 ● INJURY 10 ● MALFUNCTION 7044 ● TOTAL 7644

8 8 Oscar H Tovar CDRH / FDA/ DHHS Limitations of MDR ● Underreporting ● No incidence data ● Biased reporting ● Uncertain causality

9 Oscar H Tovar MD Food and Drug Administration Office of Device Evaluation Office of Surveillance and Biometrics

10 10 Oscar H Tovar CDRH / FDA/ DHHS ● The benefits of early defibrillation in public places have been shown in numerous studies ● There is a steady increase in deployment of automatic external defibrillators (AEDs) ● The estimated AED growth rate for the USA was 8.2% for 2000 and 2001, 11.5% for 2002 and 22.0% for 2003. It is estimated to be about 20% per year in the next 5 years* * Frost & Sullivan, September 2003 Background

11 11 Oscar H Tovar CDRH / FDA/ DHHS ● The success of early defibrillation implies that the AED works in the first attempt and consistently in the following attempts if necessary ● An AED failure to deliver a defibrillation shock decreases significantly the probability of survival of a patient in ventricular fibrillation ● There is scarce information about adverse events associated with AED use Background

12 12 Oscar H Tovar CDRH / FDA/ DHHS Goals of the Study To assess adverse event reports – particularly deaths- associated with AED failure from 1996 to 2003 To determine AED component failure or factors that resulted in failed defibrillation associated with deaths

13 13 Oscar H Tovar CDRH / FDA/ DHHS ● We reviewed Medical Device Reports (MDR) submitted by AED manufacturers to the FDA for AED-related adverse events. ● MDRs were received from 8-19-1996 to 12-31-2003. ● We analyzed MDRs using the Manufacturer and User Facility Device Experience (MAUDE) database from the FDA. Methods

14 14 Oscar H Tovar CDRH / FDA/ DHHS Methods ● The manufacturer results and conclusion codes (following failure analyses) were used to assess the association of device and component failure with a patient death. Both results and conclusions were grouped in categories.

15 15 Oscar H Tovar CDRH / FDA/ DHHS Adverse Events 1996-1999

16 16 Oscar H Tovar CDRH / FDA/ DHHS Adverse Events 2000-2003

17 17 Oscar H Tovar CDRH / FDA/ DHHS Adverse Events 2000-20031996-1999

18 18 Oscar H Tovar CDRH / FDA/ DHHS AED Malfunctions 1996-2003

19 19 Oscar H Tovar CDRH / FDA/ DHHS AED Injuries 1996-2003

20 20 Oscar H Tovar CDRH / FDA/ DHHS AED-Associated Deaths

21 21 Oscar H Tovar CDRH / FDA/ DHHS Manufacturers’ Conclusions 1996-1999 Percent

22 22 Oscar H Tovar CDRH / FDA/ DHHS Manufacturers’ Conclusions 2000-2003 Percent

23 23 Oscar H Tovar CDRH / FDA/ DHHS Manufacturers’ Conclusions 1996-2003 2000-2003 1996-1999 Percent

24 24 Oscar H Tovar CDRH / FDA/ DHHS Component Failure 1996-1999 Percent

25 25 Oscar H Tovar CDRH / FDA/ DHHS Component Failure 2000-2003 Percent

26 26 Oscar H Tovar CDRH / FDA/ DHHS Component Failure 1996-2003 2000-2003 1996-1999 Percent

27 27 Oscar H Tovar CDRH / FDA/ DHHS AED Recalls 1996-2003

28 28 Oscar H Tovar CDRH / FDA/ DHHS Conclusions The results suggest that: ● The number of reported deaths associated with AED failure is markedly more frequent than injuries ● Reported AED failure is increasing, along with increase in AED deployment

29 29 Oscar H Tovar CDRH / FDA/ DHHS Conclusions ● There is a relative decrease in reported electrical component failure ● There is relative decrease in reported device operation outside specifications (which includes use error)


Download ppt "Adverse Event Reports on Automatic External Defibrillators from 1996 - 2003 Oscar H Tovar MD and Beverly Gallauresi RN, MPH Food and Drug Administration."

Similar presentations


Ads by Google